Effect of sleep apnea on cognition and mood (Q34455375)

2 August 2017

1 reference

title

Effect of sleep apnea on cognition and mood (English)

1 reference

2 August 2017

1 reference

Baruch El-Ad

1

1 reference

2 August 2017

Peretz Lavie

series ordinal

2

1 reference

2 August 2017

publication date

1 August 2005

1 reference

International Review of Psychiatry

2 August 2017

published in

1 reference

2 August 2017

volume

17

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

277-282

1 reference

Physiological and psychological differences between good and poor sleepers

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Next-day memory impairment with triazolam use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Prevalence of sleep disorders in the Los Angeles metropolitan area

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Treating insomnia: pharmacological and nonpharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Insomnia, metabolic rate and sleep restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Electrodermal activity in patients with persistent insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Overcoming Obstacles: Therapeutic Success Despite External Barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Doxepin in the Treatment of Primary Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Insomniacs' reported use of CBT components and relationship to long-term clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Court Appointed Volunteers for Abused and Neglected Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Biopsychobehavioral correlates of insomnia. II. Pattern specificity and consistency with the Minnesota Multiphasic Personality Inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Sleep disorders: insomnia, sleepwalking, night terrors, nightmares, and enuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Biopsychobehavioral correlates of insomnia, V: Clinical characteristics and behavioral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Prevalence of sleep disturbance in a primarily urban Florida County

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Clinical correlates of insomnia in patients with chronic illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Rebound insomnia and newer hypnotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Brief integrative dynamic psychotherapy for insomnia. Systematic evaluation of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Temporal and stagewise distribution of high frequency EEG activity in patients with primary and secondary insomnia and in good sleeper controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Response to "Idiopathic hypersomnia: a diagnostic dilemma" (J. Montplaisir and L. Fantini).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Over-the-counter sleep aids: widely used but rarely studied

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Effects of acute administration of brotizolam in subjects with disturbed sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Entrainment of free-running circadian rhythms by melatonin in blind people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Insomnia in relation to depression and anxiety: epidemiologic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Hypnotic Effectiveness of Sodium Salicylamide with Short-Term Use: Sleep Laboratory Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Sleep disorder over time: psychiatric correlates among males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

21 January 2018

Sleep and its disorders

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

The morbidity of insomnia uncomplicated by psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260500104508

10.1080/09540260500104508

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference